Study Summary
This trial is testing new MRI imaging techniques to see if they provide better images than standard MRI for patients with brain cancer.
Eligible Conditions
- Brain Metastasis
- Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: through study completion, an average of 1 year
Year 1
Conspicuity
Sensitivity
Treatment response
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Diagnostic (advanced MRI)
1 of 1
Experimental Treatment
50 Total Participants · 1 Treatment Group
Primary Treatment: Conventional Magnetic Resonance Imaging · No Placebo Group · N/A
Diagnostic (advanced MRI)Experimental Group · 2 Interventions: Conventional Magnetic Resonance Imaging, Advanced Magnetic Resonance Imaging · Intervention Types: Procedure, Procedure
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,810 Previous Clinical Trials
1,790,521 Total Patients Enrolled
Jason M JohnsonPrincipal InvestigatorM.D. Anderson Cancer Center
6 Previous Clinical Trials
178 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:The MRI of the brain reveals at least one lesion that is greater than 5 mm in size which is most likely to be a metastasis.
A patient who has been diagnosed with cancer that has spread to one or more organs is considered to have a solid organ cancer.
therapy
The patient will undergo a series of stereotactic radiation therapy treatments.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments